title: Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients.
abstract: Cyclosporine A (CyA) is a standard component of immunosuppressive regimens. It is a critical-dose drug for which a minor change in absorption can have important clinical consequences. The aim of the study was to compare the pharmacokinetics and safety of the new generic CyA formulation, Equoral capsules, after a switch from original formulation, Neoral capsules, in seventy stable adult renal transplant recipients. The extent and rate of pharmacokinetic parameters for bioequivalence were compared in a non-randomized, steady-state clinical study with fixed non-replicate study design. Pharmacokinetic analysis of CyA have shown that both the rate and extent of absorption of Equoral does not differ significantly from that of Neoral. At identical dosing, the new formulation was found to have geometric means of C(max) 717 ng/ml and AUCtau 3108 ng/ml.h, while corresponding results of comparator were 725 ng/ml and AUCtau 3039 ng/ml.h, respectively. The 90 % confidence intervals of C(max) and AUCtau were within 80- 125 % interval of the mean values. The results suggest that Equoral capsules can be used as an alternative treatment to Neoral capsules in CyA regimen.
authors.affiliation: Institute of Pharmacology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. fperl@lf1.cuni.cz
authors.forename: Frantisek
authors.initials: F
authors.lastname: Perlík
authors.forename: Marwan A
authors.initials: MA
authors.lastname: Masri
authors.forename: M
authors.initials: M
authors.lastname: Rost
authors.forename: Vojtĕch
authors.initials: V
authors.lastname: Kamarád
mesh_terms: D000042:Absorption; D000328:Adult; D002214:Capsules; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D016030:Kidney Transplantation; D008297:Male
chemical_list: D002214:Capsules; D007166:Immunosuppressive Agents; D016572:Cyclosporine